BRCA1 and p53 regulate critical prostate cancer pathways

Background:Loss or mutations of the BRCA1 gene are associated with increased risk of breast and ovarian cancers and with prostate cancer (PCa) aggressiveness. Previously, we identified GADD153 as a target of BRCA1 protein, which increases doxorubicin sensitivity in human p53 -/- PCa cells (PC3). Con...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: De Luca, Paola, Moiola, Cristian Pablo, Vázquez, Elba Susana, De Siervi, Adriana
Publicado: 2013
Materias:
p53
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_13657852_v16_n3_p233_DeLuca
http://hdl.handle.net/20.500.12110/paper_13657852_v16_n3_p233_DeLuca
Aporte de:
id paper:paper_13657852_v16_n3_p233_DeLuca
record_format dspace
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic BRCA1
DNA damage
GADD153
p53
beta catenin
Bloom syndrome helicase
BRCA1 protein
BRCA2 protein
cyclin D1
cyclin dependent kinase inhibitor 1
fibronectin
growth arrest and DNA damage inducible protein 153
luciferase
protein p53
protein Patched 1
sonic hedgehog protein
transcription factor Gli1
transcription factor Slug
transcription factor Snail
uvomorulin
vimentin
actin B gene
animal experiment
animal model
animal tissue
article
beta catenin gene
BLM gene
CCNB2 gene
cell cycle regulation
cell strain LNCaP
chromatin immunoprecipitation
controlled study
Cyclin D1 gene
DDB2 gene
DNA damage
E cadherin gene
enzyme assay
epithelial mesenchymal transition
FEN1 gene
fibronectin gene
GADD153 gene
Gadd45a gene
gene
gene expression
GLI1 gene
H3F3B gene
in vivo study
male
mouse
nonhuman
p21 WAF1 CIP1 gene
patch1 gene
priority journal
prostate cancer
protein expression
quantitative analysis
reverse transcription polymerase chain reaction
SHH gene
Slug gene
Snail gene
transcription regulation
tumor suppressor gene
Vimentin gene
Western blotting
Animals
BRCA1 Protein
Cell Cycle
Cell Line, Tumor
DNA Damage
Hedgehogs
Heterografts
Humans
Male
Mice
Prostatic Neoplasms
Reverse Transcriptase Polymerase Chain Reaction
Signal Transduction
Transcription Factor CHOP
Transcription, Genetic
Tumor Suppressor Protein p53
spellingShingle BRCA1
DNA damage
GADD153
p53
beta catenin
Bloom syndrome helicase
BRCA1 protein
BRCA2 protein
cyclin D1
cyclin dependent kinase inhibitor 1
fibronectin
growth arrest and DNA damage inducible protein 153
luciferase
protein p53
protein Patched 1
sonic hedgehog protein
transcription factor Gli1
transcription factor Slug
transcription factor Snail
uvomorulin
vimentin
actin B gene
animal experiment
animal model
animal tissue
article
beta catenin gene
BLM gene
CCNB2 gene
cell cycle regulation
cell strain LNCaP
chromatin immunoprecipitation
controlled study
Cyclin D1 gene
DDB2 gene
DNA damage
E cadherin gene
enzyme assay
epithelial mesenchymal transition
FEN1 gene
fibronectin gene
GADD153 gene
Gadd45a gene
gene
gene expression
GLI1 gene
H3F3B gene
in vivo study
male
mouse
nonhuman
p21 WAF1 CIP1 gene
patch1 gene
priority journal
prostate cancer
protein expression
quantitative analysis
reverse transcription polymerase chain reaction
SHH gene
Slug gene
Snail gene
transcription regulation
tumor suppressor gene
Vimentin gene
Western blotting
Animals
BRCA1 Protein
Cell Cycle
Cell Line, Tumor
DNA Damage
Hedgehogs
Heterografts
Humans
Male
Mice
Prostatic Neoplasms
Reverse Transcriptase Polymerase Chain Reaction
Signal Transduction
Transcription Factor CHOP
Transcription, Genetic
Tumor Suppressor Protein p53
De Luca, Paola
Moiola, Cristian Pablo
Vázquez, Elba Susana
De Siervi, Adriana
BRCA1 and p53 regulate critical prostate cancer pathways
topic_facet BRCA1
DNA damage
GADD153
p53
beta catenin
Bloom syndrome helicase
BRCA1 protein
BRCA2 protein
cyclin D1
cyclin dependent kinase inhibitor 1
fibronectin
growth arrest and DNA damage inducible protein 153
luciferase
protein p53
protein Patched 1
sonic hedgehog protein
transcription factor Gli1
transcription factor Slug
transcription factor Snail
uvomorulin
vimentin
actin B gene
animal experiment
animal model
animal tissue
article
beta catenin gene
BLM gene
CCNB2 gene
cell cycle regulation
cell strain LNCaP
chromatin immunoprecipitation
controlled study
Cyclin D1 gene
DDB2 gene
DNA damage
E cadherin gene
enzyme assay
epithelial mesenchymal transition
FEN1 gene
fibronectin gene
GADD153 gene
Gadd45a gene
gene
gene expression
GLI1 gene
H3F3B gene
in vivo study
male
mouse
nonhuman
p21 WAF1 CIP1 gene
patch1 gene
priority journal
prostate cancer
protein expression
quantitative analysis
reverse transcription polymerase chain reaction
SHH gene
Slug gene
Snail gene
transcription regulation
tumor suppressor gene
Vimentin gene
Western blotting
Animals
BRCA1 Protein
Cell Cycle
Cell Line, Tumor
DNA Damage
Hedgehogs
Heterografts
Humans
Male
Mice
Prostatic Neoplasms
Reverse Transcriptase Polymerase Chain Reaction
Signal Transduction
Transcription Factor CHOP
Transcription, Genetic
Tumor Suppressor Protein p53
description Background:Loss or mutations of the BRCA1 gene are associated with increased risk of breast and ovarian cancers and with prostate cancer (PCa) aggressiveness. Previously, we identified GADD153 as a target of BRCA1 protein, which increases doxorubicin sensitivity in human p53 -/- PCa cells (PC3). Considering that p53 is a crucial target in cancer therapy, in this work we investigated p53 role in the regulation of transcription of GADD153.Methods:We performed reverse transcription quantitative PCR (RT-qPCR), western blot and luciferase assays to analyze GADD153 and/or BRCA1 expression in response to ultraviolet or doxorubicin exposure in PC3 p53 stable-transfected cells and LNCaP (p53+/+) cells. BRCA1 protein recruitment to GADD153 promoter was studied by chromatin immunoprecipitation-qPCR. To assess expression of BRCA1 and/or p53 target genes, we used a panel of stable-transfected PCa cell lines. We finally analyzed these genes in vivo using BRCA1-depleted PCa xenograft models.Results:We found that GADD153 was highly induced by doxorubicin in PC3 cells; however, this response was totally abolished in LNCaP (p53wt) and in p53-restituted PC3 cells. Furthermore, BRCA1 protein associates to GADD153 promoter after DNA damage in the presence of p53. Additionally, we demonstrated that BRCA1 and/or p53 modulate genes involved in DNA damage and cell cycle regulation (cyclin D1, BLM, BRCA2, DDB2, p21 WAF1/CIP1, H3F3B, GADD153, GADD45A, FEN1, CCNB2), EMT (E-cadherin, β-catenin, vimentin, fibronectin, slug, snail) and Hedgehog pathways (SHH, IHH, DHH, Gli1, PATCH1). Furthermore, xenograft studies demonstrated that BRCA1 knockdown in PC3 cells increased tumor growth and modulated these genes in vivo.Conclusions:Although BRCA1 induces GADD153 in a p53 independent manner, p53 abolished GADD153 induction in response to DNA damage. In addition, several important PCa targets are modulated by BRCA1 and p53. Altogether, these data might be important to understand the therapy response of PCa patients.© 2013 Macmillan Publishers Limited All rights reserved.
author De Luca, Paola
Moiola, Cristian Pablo
Vázquez, Elba Susana
De Siervi, Adriana
author_facet De Luca, Paola
Moiola, Cristian Pablo
Vázquez, Elba Susana
De Siervi, Adriana
author_sort De Luca, Paola
title BRCA1 and p53 regulate critical prostate cancer pathways
title_short BRCA1 and p53 regulate critical prostate cancer pathways
title_full BRCA1 and p53 regulate critical prostate cancer pathways
title_fullStr BRCA1 and p53 regulate critical prostate cancer pathways
title_full_unstemmed BRCA1 and p53 regulate critical prostate cancer pathways
title_sort brca1 and p53 regulate critical prostate cancer pathways
publishDate 2013
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_13657852_v16_n3_p233_DeLuca
http://hdl.handle.net/20.500.12110/paper_13657852_v16_n3_p233_DeLuca
work_keys_str_mv AT delucapaola brca1andp53regulatecriticalprostatecancerpathways
AT moiolacristianpablo brca1andp53regulatecriticalprostatecancerpathways
AT vazquezelbasusana brca1andp53regulatecriticalprostatecancerpathways
AT desierviadriana brca1andp53regulatecriticalprostatecancerpathways
_version_ 1768542378237362176
spelling paper:paper_13657852_v16_n3_p233_DeLuca2023-06-08T16:12:01Z BRCA1 and p53 regulate critical prostate cancer pathways De Luca, Paola Moiola, Cristian Pablo Vázquez, Elba Susana De Siervi, Adriana BRCA1 DNA damage GADD153 p53 beta catenin Bloom syndrome helicase BRCA1 protein BRCA2 protein cyclin D1 cyclin dependent kinase inhibitor 1 fibronectin growth arrest and DNA damage inducible protein 153 luciferase protein p53 protein Patched 1 sonic hedgehog protein transcription factor Gli1 transcription factor Slug transcription factor Snail uvomorulin vimentin actin B gene animal experiment animal model animal tissue article beta catenin gene BLM gene CCNB2 gene cell cycle regulation cell strain LNCaP chromatin immunoprecipitation controlled study Cyclin D1 gene DDB2 gene DNA damage E cadherin gene enzyme assay epithelial mesenchymal transition FEN1 gene fibronectin gene GADD153 gene Gadd45a gene gene gene expression GLI1 gene H3F3B gene in vivo study male mouse nonhuman p21 WAF1 CIP1 gene patch1 gene priority journal prostate cancer protein expression quantitative analysis reverse transcription polymerase chain reaction SHH gene Slug gene Snail gene transcription regulation tumor suppressor gene Vimentin gene Western blotting Animals BRCA1 Protein Cell Cycle Cell Line, Tumor DNA Damage Hedgehogs Heterografts Humans Male Mice Prostatic Neoplasms Reverse Transcriptase Polymerase Chain Reaction Signal Transduction Transcription Factor CHOP Transcription, Genetic Tumor Suppressor Protein p53 Background:Loss or mutations of the BRCA1 gene are associated with increased risk of breast and ovarian cancers and with prostate cancer (PCa) aggressiveness. Previously, we identified GADD153 as a target of BRCA1 protein, which increases doxorubicin sensitivity in human p53 -/- PCa cells (PC3). Considering that p53 is a crucial target in cancer therapy, in this work we investigated p53 role in the regulation of transcription of GADD153.Methods:We performed reverse transcription quantitative PCR (RT-qPCR), western blot and luciferase assays to analyze GADD153 and/or BRCA1 expression in response to ultraviolet or doxorubicin exposure in PC3 p53 stable-transfected cells and LNCaP (p53+/+) cells. BRCA1 protein recruitment to GADD153 promoter was studied by chromatin immunoprecipitation-qPCR. To assess expression of BRCA1 and/or p53 target genes, we used a panel of stable-transfected PCa cell lines. We finally analyzed these genes in vivo using BRCA1-depleted PCa xenograft models.Results:We found that GADD153 was highly induced by doxorubicin in PC3 cells; however, this response was totally abolished in LNCaP (p53wt) and in p53-restituted PC3 cells. Furthermore, BRCA1 protein associates to GADD153 promoter after DNA damage in the presence of p53. Additionally, we demonstrated that BRCA1 and/or p53 modulate genes involved in DNA damage and cell cycle regulation (cyclin D1, BLM, BRCA2, DDB2, p21 WAF1/CIP1, H3F3B, GADD153, GADD45A, FEN1, CCNB2), EMT (E-cadherin, β-catenin, vimentin, fibronectin, slug, snail) and Hedgehog pathways (SHH, IHH, DHH, Gli1, PATCH1). Furthermore, xenograft studies demonstrated that BRCA1 knockdown in PC3 cells increased tumor growth and modulated these genes in vivo.Conclusions:Although BRCA1 induces GADD153 in a p53 independent manner, p53 abolished GADD153 induction in response to DNA damage. In addition, several important PCa targets are modulated by BRCA1 and p53. Altogether, these data might be important to understand the therapy response of PCa patients.© 2013 Macmillan Publishers Limited All rights reserved. Fil:De Luca, P. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Moiola, C.P. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Vazquez, E.S. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:De Siervi, A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. 2013 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_13657852_v16_n3_p233_DeLuca http://hdl.handle.net/20.500.12110/paper_13657852_v16_n3_p233_DeLuca